BillionToOne to Participate in Two Upcoming Investor Conferences
MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company will participate in two upcoming investor conferences.
- UBS Global Healthcare Conference 2026
Fireside Chat on Tuesday, November 10th at 2:00 PM ET
- Stifel 2026 Healthcare Conference
Fireside Chat on Wednesday, November 11th at 3:20 PM ET
A live and archived webcast of the events will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
rachel@fordhutmanmedia.com
Mentioned In This Article
Latest News
| Oct-27 | |
| Oct-27 | |
| Oct-21 | |
| Oct-14 | |
| Oct-07 | |
| Sep-23 | |
| Sep-02 | |
| Sep-01 | |
| Aug-18 | |
| Aug-06 | |
| Aug-06 | |
| Aug-05 | |
| Aug-05 | |
| Aug-04 | |
| Aug-03 |
Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test
BLLN
Investor's Business Daily
|
